Menopausal hormone therapy and breast cancer risk: All progestogens are not the same.
作者信息
Lambrinoudaki Irene
机构信息
National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
出版信息
Case Rep Womens Health. 2020 Nov 12;29:e00270. doi: 10.1016/j.crwh.2020.e00270. eCollection 2021 Jan.
Abstract
摘要
相似文献
1
Menopausal hormone therapy and breast cancer risk: All progestogens are not the same.
Case Rep Womens Health. 2020 Nov 12;29:e00270. doi: 10.1016/j.crwh.2020.e00270. eCollection 2021 Jan.
2
3
Hormone replacement therapy and cancer.
Gynecol Endocrinol. 2001 Dec;15(6):453-65.
4
The choice of progestogen for HRT in menopausal women: breast cancer risk is a major issue.
Horm Mol Biol Clin Investig. 2018 Aug 18;37(1):hmbci-2018-0019. doi: 10.1515/hmbci-2018-0019.
5
Differential Effects of Progestogens Used for Menopausal Hormone Therapy.
Clin Obstet Gynecol. 2018 Sep;61(3):454-462. doi: 10.1097/GRF.0000000000000364.
6
The Effect of Menopausal Hormone Therapies on Breast Cancer: Avoiding the Risk.
Endocrinol Metab Clin North Am. 2015 Sep;44(3):587-602. doi: 10.1016/j.ecl.2015.05.007. Epub 2015 Jun 23.
7
Progestogens as a component of menopausal hormone therapy: the right molecule makes the difference.
Drugs Context. 2020 Dec 2;9. doi: 10.7573/dic.2020-10-1. eCollection 2020.
8
Progestogen use in women approaching the menopause and breast cancer risk.
Maturitas. 2009 Apr 20;62(4):338-42. doi: 10.1016/j.maturitas.2008.10.017. Epub 2008 Dec 31.
9
Progestogens in menopausal hormone therapy.
Prz Menopauzalny. 2015 Jun;14(2):134-43. doi: 10.5114/pm.2015.52154. Epub 2015 Jun 22.
10
Psychological effects of progestogens in the post-menopausal years.
Maturitas. 1986 Jul;8(2):101-6. doi: 10.1016/0378-5122(86)90016-2.
引用本文的文献
1
Menopausal Hormone Therapy in Breast Cancer Survivors.
Cancers (Basel). 2024 Sep 26;16(19):3267. doi: 10.3390/cancers16193267.
2
The 100 top-cited articles in menopausal syndrome: a bibliometric analysis.
Reprod Health. 2024 Apr 8;21(1):47. doi: 10.1186/s12978-024-01770-9.
3
Levonorgestrel intrauterine system and breast cancer risk: An updated systematic review and meta-analysis of observational studies.
Heliyon. 2023 Mar 22;9(4):e14733. doi: 10.1016/j.heliyon.2023.e14733. eCollection 2023 Apr.
4
Perceptions, Benefits, and Use of Complementary and Integrative Therapies to Treat Menopausal Symptoms: A Pilot Study.
Womens Health Rep (New Rochelle). 2023 Mar 27;4(1):136-147. doi: 10.1089/whr.2022.0105. eCollection 2023.
5
Identification of Candidate Genes in Breast Cancer Induced by Estrogen Plus Progestogens Using Bioinformatic Analysis.
Int J Mol Sci. 2022 Oct 6;23(19):11892. doi: 10.3390/ijms231911892.
6
Breast Cancer Incidence Reduction in Women Treated with Subcutaneous Testosterone: Testosterone Therapy and Breast Cancer Incidence Study.
Eur J Breast Health. 2021 Mar 31;17(2):150-156. doi: 10.4274/ejbh.galenos.2021.6213. eCollection 2021 Apr.
本文引用的文献
1
Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases.
BMJ. 2020 Oct 28;371:m3873. doi: 10.1136/bmj.m3873.
2
Premature ovarian insufficiency: an International Menopause Society White Paper.
Climacteric. 2020 Oct;23(5):426-446. doi: 10.1080/13697137.2020.1804547. Epub 2020 Sep 8.
3
Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials.
JAMA. 2020 Jul 28;324(4):369-380. doi: 10.1001/jama.2020.9482.
4
Menopausal hormone therapy and breast cancer: Need to put risks in perspective.
Maturitas. 2020 Jan;131:89-90. doi: 10.1016/j.maturitas.2019.09.001. Epub 2019 Sep 10.
5
Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.
Lancet. 2019 Sep 28;394(10204):1159-1168. doi: 10.1016/S0140-6736(19)31709-X. Epub 2019 Aug 29.
6
Maintaining postreproductive health: A care pathway from the European Menopause and Andropause Society (EMAS).
Maturitas. 2016 Jul;89:63-72. doi: 10.1016/j.maturitas.2016.04.013. Epub 2016 Apr 20.
7
Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials.
JAMA Oncol. 2015 Jun;1(3):296-305. doi: 10.1001/jamaoncol.2015.0494.
8
Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study.
Breast Cancer Res Treat. 2008 Jan;107(1):103-11. doi: 10.1007/s10549-007-9523-x. Epub 2007 Feb 27.
Zotero 插件